Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference

Company Overview - Erasca, Inc. is a clinical-stage precision oncology company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers [3] - The company aims to "erase cancer" by creating novel therapies and combination regimens that comprehensively target the RAS/MAPK pathway [3] Upcoming Event - Erasca will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026, at 1:30 pm Pacific Time [1] - The company will also engage in one-on-one investor meetings during the conference [1] Event Accessibility - A live audio webcast of the event will be available on Erasca's website [2] - An archived replay of the event will be accessible for 30 days following the live webcast [2]